1 – 13 of 13
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19 : A Consensus Statement Based on Available Clinical Trials
(
- Contribution to journal › Scientific review
-
Mark
Thromboembolic Disease in Patients With Cancer and COVID-19 : Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art
(
- Contribution to journal › Scientific review
-
Mark
Plaque characteristics and biomarkers predicting regression and progression of carotid atherosclerosis
(
- Contribution to journal › Article
- 2019
-
Mark
Urgent need to clarify the definition of chronic critical limb ischemia – a position paper from the european society for vascular medicine
(
- Contribution to journal › Article
-
Mark
The compelling arguments for the need of medical vascular physicians in Europe
(
- Contribution to journal › Article
-
Mark
ESVM Guideline on peripheral arterial disease
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes : The SUMMIT VIP Study
(
- Contribution to journal › Article
- 2017
-
Mark
ESVM guidelines – the diagnosis and management of raynaud’s phenomenon
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes
(
- Contribution to journal › Article
- 2015
-
Mark
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
(
- Contribution to journal › Article
- 2008
-
Mark
MQX-503, a novel topical nitroglycerin formulation, improves severity of symptoms associated with Raynaud's phenomenon
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.622-622(
- Contribution to journal › Published meeting abstract
-
Mark
Comparison of responders and non-responders to MQX-503, a novel investigational topical nitroglycerin formulation, in treatment of scieroderma-related and non-scleroderma-related Raynaud'S phenomenon
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.822-822(
- Contribution to journal › Published meeting abstract
-
Mark
Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.821-821(
- Contribution to journal › Published meeting abstract